Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Insilico Medicine Hong Kong Limited

Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.

Trials to join now! 2 Completed 1
Sort by
  • New pill aims to slow lung scarring in IPF patients

    Disease control Recruiting now

    This study tests an oral drug called INS018_055 in 40 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing problems. The main goal is to check the drug's safety over 12 weeks. Researchers will also measure how the drug moves through t…

    Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control

    Last updated May 01, 2026 23:59 UTC

  • New pill could tame gut inflammation in colitis patients

    Disease control Recruiting now

    This study tests a new drug called ISM5411 in 80 adults with active ulcerative colitis, a condition causing inflammation in the colon. Participants will receive either the drug or a placebo to see if it is safe and helps control symptoms. The goal is to manage the disease, not cu…

    Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control

    Last updated May 01, 2026 23:58 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space